These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7679351)

  • 1. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells.
    Kato J; Misko TP; Currie MG
    Eur J Pharmacol; 1993 Jan; 244(2):153-9. PubMed ID: 7679351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP.
    Zhang LM; Tao H; Newman WH
    Am J Physiol; 1993 Jun; 264(6 Pt 2):H1753-9. PubMed ID: 8391754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
    Marumo T; Nakaki T; Hishikawa K; Hirahashi J; Suzuki H; Kato R; Saruta T
    Endocrinology; 1995 May; 136(5):2135-42. PubMed ID: 7536663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells.
    Cahill PA; Redmond EM; Foster C; Sitzmann JV
    Eur J Pharmacol; 1995 Jan; 288(2):219-29. PubMed ID: 7536678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.
    Kato J; Lanier-Smith KL; Currie MG
    J Biol Chem; 1991 Aug; 266(22):14681-5. PubMed ID: 1650366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in effect of atrial natriuretic peptide on cGMP in aortic and coronary smooth muscle cells.
    Newman WH; Kato J; Becker BF; Currie MG
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H710-4. PubMed ID: 1329536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
    J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D; McGuiggin M
    J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant erythropoietin inhibits interleukin-1beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells.
    Kusano E; Akimoto T; Inoue M; Masunaga Y; Umino T; Ono S; Ando Y; Homma S; Muto S; Komatsu N; Asano Y
    Nephrol Dial Transplant; 1999 Mar; 14(3):597-603. PubMed ID: 10193805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
    Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
    Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 beta induces the formation of nitric oxide in isolated juxtaglomerular cells: influence on renin secretion.
    Galle J; Schini VB; Stunz P; Wanner C; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(2):191-7. PubMed ID: 7538649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.
    Boese M; Busse R; Mülsch A; Schini-Kerth V
    Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.
    Busse R; Mülsch A
    FEBS Lett; 1990 Nov; 275(1-2):87-90. PubMed ID: 1702067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
    Green DF; Duruibe VA; Blyden G; Laskey RE; Bourgoignie JJ
    J Am Soc Nephrol; 1994 Oct; 5(4):1091-8. PubMed ID: 7849248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
    Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
    Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.
    Papapetropoulos A; Abou-Mohamed G; Marczin N; Murad F; Caldwell RW; Catravas JD
    Br J Pharmacol; 1996 Jul; 118(6):1359-66. PubMed ID: 8832057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor.
    Sabrane K; Gambaryan S; Brandes RP; Holtwick R; Voss M; Kuhn M
    J Biol Chem; 2003 May; 278(20):17963-8. PubMed ID: 12637561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide: a modulator for the epidermal growth factor receptor expression in developing ovarian granulosa cells.
    Hattori M; Sakamoto K; Fujihara N; Kojima I
    Am J Physiol; 1996 Mar; 270(3 Pt 1):C812-8. PubMed ID: 8638661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors.
    Papapetropoulos A; Marczin N; Catravas JD
    Eur J Pharmacol; 1998 Mar; 344(2-3):313-21. PubMed ID: 9600668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
    Beasley D; Schwartz JH; Brenner BM
    J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.